Microbiota Influences Vaccine and Mucosal Adjuvant Efficacy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
A symbiotic relationship between humans and the microbiota is critical for the maintenance of our health, including development of the immune system, enhancement of the epithelial barrier, and acquisition of nutrients. Recent research has shown that the microbiota impacts immune cell development and differentiation. These findings suggest that the microbiota may also influence adjuvant and vaccine efficacy. Indeed, several factors such as malnutrition and poor sanitation, which affect gut microbiota composition, impair the efficacy of vaccines. Although there is little evidence that microbiota alters vaccine efficacy, further understanding of human immune system-microbiota interactions may lead to the effective development of adjuvants and vaccines for the treatment of diseases.
Abstract
A symbiotic relationship between humans and the microbiota is critical for the maintenance of our health, including development of the immune system, enhancement of the epithelial barrier, and acquisition of nutrients. Recent research has shown that the microbiota impacts immune cell development and differentiation. These findings suggest that the microbiota may also influence adjuvant and vaccine efficacy. Indeed, several factors such as malnutrition and poor sanitation, which affect gut microbiota composition, impair the efficacy of vaccines. Although there is little evidence that microbiota alters vaccine efficacy, further understanding of human immune system-microbiota interactions may lead to the effective development of adjuvants and vaccines for the treatment of diseases.
참고문헌 (38)
- Kamada, N., "Role of the gut microbiota in immunity and inflammatory disease", Nat. Rev. Immunol, 13, pp.321~335 (2013)
- McKenney, P. T., "From hype to hope : The gut microbiota in enteric infectious disease", Cell, 163, pp.1326~1332 (2015)
- Tanoue, T., "Development and maintenance of intestinal regulatory T cells", Nat. Rev. Immunol, 16, pp.295~309 (2016)
- Belkaid, Y., "Role of the microbiota in immunity and inflammation", Cell, 157, pp.121~141 (2014)
- Round, J. L., "The gut microbiota shapes intestinal immune responses during health and disease", Nat. Rev. Immunol, 9, pp.313~323 (2009)
- Mazmanian, S. K., "An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system", Cell, 122, pp.107~118 (2005)
- Macpherson, A. J., "Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria", Science, 303, pp.1662~1665 (2004)
- Zeng, M. Y., "Gut microbiota-induced immunoglobulin G controls systemic infection by symbiotic bacteria and pathogens", Immunity, 44, pp.647~658 (2016)
- Bouskra, D., "Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis", Nature, 456, pp.507~510 (2008)
- Hansen, C. H., "Patterns of early gut colonization shape future immune responses of the host", PLoS One, 7, pp.e34043~ (2012)
- Kawai, T., "The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors", Nat. Immunol, 11, pp.373~384 (2010)
- Motta, V., "NOD-like receptors: versatile cytosolic sentinels", Physiol Rev, 95, pp.149~178 (2015)
- den, B. G., "The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism", J. Lipid Res, 54, pp.2325~2340 (2013)
- Davie, J. R., "Inhibition of histone deacetylase activity by butyrate", J. Nutr, 133, pp.2485S~2493S (2003)
- Furusawa, Y., "Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells", Nature, 504, pp.446~450 (2013)
- Vesikari, T., "Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine", Lancet, 1, pp.977~981 (1984)
- John, T. J., "Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference", Am. J. Epidemiol, 96, pp.263~269 (1972)
- Patriarca, P. A., "Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review", Rev. Infect. Dis, 13, pp.926~939 (1991)
- Jiang, V., "Performance of rotavirus vaccines in developed and developing countries", Hum. Vaccin, 6, pp.532~542 (2010)
- Lopman, B. A., "Understanding reduced rotavirus vaccine efficacy in low socio-economic settings", PLoS One, 7, pp.e41720~ (2012)
- Hallander, H. O., "Calibrated serological techniques demonstrate significant different serum response rates to an oral killed cholera vaccine between Swedish and Nicaraguan children", Vaccine, 21, pp.138~145 (2002)
- Grassly, N. C., "Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India", J. Infect. Dis, 200, pp.794~801 (2009)
- De, F. C., "Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa", Proc. Natl. Acad. Sci. U. S. A, 107, pp.14691~14696 (2010)
- Huda, M. N., "Stool microbiota and vaccine responses of infants", Pediatrics, 134, pp.e362~e372 (2014)
- Lagos, R., "Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR", J. Infect. Dis, 180, pp.1709~1712 (1999)
- Reikie, B. A., "Ontogeny of Toll-like receptor mediated cytokine responses of South African infants throughout the first year of life", PLoS One, 7, pp.e44763~ (2012)
- Smolen, K. K., "Pattern recognition receptor-mediated cytokine response in infants across 4 continents", J. Allergy Clin. Immunol, 133, pp.818~826 (2014)
- Woo, P. C., "Antibiotics modulate vaccine-induced humoral immune response", Clin. Diagn. Lab. Immunol, 6, pp.832~837 (1999)
- Seekatz, A. M., "Differential response of the cynomolgus macaque gut microbiota to Shigella infection", PLoS One, 8, pp.e64212~ (2013)
- Benyacoub, J., "Feeding a diet containing a fructooligosaccharide mix can enhance Salmonella vaccine efficacy in mice", J. Nutr, 138, pp.123~129 (2008)
- Vos, A. P., "A specific prebiotic oligosaccharide mixture stimulates delayed-type hypersensitivity in a murine influenza vaccination model", Int. Immunopharmacol, 6, pp.1277~1286 (2006)
- Petrovsky, N., "Vaccine adjuvants:current state and future trends", Immunol. Cell Biol, 82, pp.488~496 (2004)
- Dambuza, I. M., "C-type lectins in immunity: recent developments", Curr. Opin. Immunol, 32, pp.21~27 (2015)
- Nakaya, H. I., "Systems biology of vaccination for seasonal influenza in humans", Nat. Immunol, 12, pp.786~795 (2011)
- Oh, J. Z., "TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination", Immunity, 41, pp.478~492 (2014)
- Lycke, N., "The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity", Eur. J. Immunol, 22, pp.2277~2281 (1992)
- Sunahara, R. K., "Interaction of Gsalpha with the cytosolic domains of mammalian adenylyl cyclase", J. Biol. Chem, 272, pp.22265~22271 (1997)
- Kim, D., "Nod2-mediated recognition of the microbiota is critical for mucosal adjuvant activity of cholera toxin", Nat.Med, 22, pp.524~530 (2016)
